✦ LIBER ✦

Adverse Events and Patient Tolerability of Apomorphine SL 2 and 3 mg: A Cross-Study Analysis of Phase II and III Studies

✍ Scribed by D.J. Ralph; D.J. Sleep; R.J. Perdok; R.J. Padley

Book ID: 118643297
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 108 KB
Volume: 1
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(02)00010-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cross-Study Review of the Clinical Effic

Cross-Study Review of the Clinical Efficacy of Apomorphine SL 2 and 3 mg:: Pooled Data from Three Placebo-Controlled, Fixed-Dose Crossover Studies

✍ C. Stief; R.J. Padley; R.J. Perdok; D.J. Sleep 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Venous Thromboembolic Events With Chemot

Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies

✍ Hurwitz, H. I.; Saltz, L. B.; Van Cutsem, E.; Cassidy, J.; Wiedemann, J.; Sirzen 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 159 KB

Efficacy and Tolerability of Fesoterodin

Efficacy and Tolerability of Fesoterodine in Men With Overactive Bladder: A Pooled Analysis of 2 Phase III Studies

✍ Sender Herschorn; J. Stephen Jones; Matthias Oelke; Scott MacDiarmid; Joseph T. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 337 KB

## Objectives: To assess the efficacy, safety, and tolerability of fesoterodine 4 and 8 mg in men with overactive bladder. ## Methods: This was a subanalysis of pooled data from 358 men enrolled in 2 double-blind, placebo-controlled phase iii trials. subjects with frequency and urgency or urgency

Incidence of acute phase adverse events

Incidence of acute phase adverse events following denosumab or intravenous bisphosphonates: results from a randomized, controlled phase II study in patients with breast cancer and bone metastases

✍ Cynthia Campbell-Baird; Allan Lipton; Makan Sarkeshik; Haijun Ma; Susie Jun 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 131 KB

A Long-term Survival Analysis for Phase

A Long-term Survival Analysis for Phase II Study of Postoperative Concurrent Capecitabine and Radiation Therapy for Patients With Stage II/III Rectal Cancer

✍ Lu, N.; Jin, J.; Li, Y.; Wang, S.; Wang, W.; Song, Y.; Liu, Y.; Ren, H.; Fang, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis

✍ Gerald G. Krueger; Kim A. Papp; Dow B. Stough; Keith H. Loven; Wayne P. Gulliver 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 480 KB